Research, Development and Innovation are activities that have guided J.A Saúde Animal since its establishment. The intention of its founder was to innovate in the veterinary market, offering medicines of greater effectiveness, based on protocols of easy execution and positive cost benefit. For innovation in new products and services, the company has a technical team formed by specialists, masters and doctors in Veterinary Medicine, Pharmacy, among other areas. In addition, it has an exclusive department for the research and development of new formulations, supported by laboratories for the Quality Control of Physico-Chemical and Microbiological Quality and Research, Development and Innovation (RD&I), with modern laboratory equipment.


It also maintains partnerships with technology companies and research and innovation promotion centers, such as Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Empresa Brasileira de Pesquisa Agropecuária (EMBRAPA) and Banco Nacional do Desenvolvimento (BNDES). J.A was the first veterinary industry in Brazil to achieve approval in 2008 of a technological innovation project with BNDES for the development of innovative products. This partnership has been ongoing, with the third innovation project underway.

J.A, through the “J.A Universidade” project, maintains partnerships with renowned universities throughout Brazil, supporting teaching and research in the Clinical and Surgical area of Large Animals. Among the universities contemplated by the project, we can mention the Universidade de São Paulo (USP), Universidade Federal do Goiás (UFG), Universidade Federal do Tocantins (UFT), Universidade Federal de Santa Maria (UFSM), among others.

Banco Nacional do Desenvolvimento
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Single Solutions

J.A offers single solutions, such as PRÓ-BEZERRO, TURBO-CÁLCIO, MASTITE CLÍNICA VL, EGG-PPU, GENTOPEN, METRIFIM, BLOC, among other solutions in continuous development in our laboratories in order to offer to the market safe and innovative medicines in animal health.


First penicillin antimicrobial high power and immediate action.


First and unique combination of an antimicrobial metaphylactic with an antiparasitic to ensure the sanity of calves in the first month of life.


Local anesthetic no vasoconstrictor, associating Lidocaine and Xylazine, providing potentiated anesthesia and more tranquility to the surgical procedure.


Replenishing minerals and energy supplement. Containing calcium, phosphorus, magnesium, sorbitol and methionine. For the treatment of metabolic diseases of recently calvers cows.


First centrally acting muscle relaxant in ready presentation for use equine anesthesia.


First association of potassium penicillin and gentamicin for intravenous use.